MATERNAL AND FETAL OUTCOMES IN HYPOTHYROID PREGNANT WOMEN: INSIGHTS FROM A HOSPITAL-BASED STUDY IN MANDI, HIMACHAL PRADESH

BHARGAVI DONKA; HEMENDER MAHAJAN; NALNEESH SHARMA

doi:10.22159/ijcpr.2023v15i6.3083

Authors

BHARGAVI DONKA Shri Lal Bahadur Shastri Government Medical College and Hospital, Mandi (HP), India
HEMENDER MAHAJAN Shri Lal Bahadur Shastri Government Medical College and Hospital, Mandi (HP), India
NALNEESH SHARMA Shri Lal Bahadur Shastri Government Medical College and Hospital, Mandi (HP), India

DOI:

https://doi.org/10.22159/ijcpr.2023v15i6.3083

Keywords:

Thyroid disorders, Hypothyroidism, Pregnancy complications, L thyroxine, Maternal outcomes, Neonatal outcomes, Thyroid-stimulating hormone, Antenatal care, Mandi, Himachal Pradesh

Abstract

Objective: Thyroid disorders significantly impact maternal and fetal health during pregnancy, with thyroid hormone balance being crucial for fetal development. Hypothyroidism, a common disorder among women of childbearing age, can lead to adverse pregnancy outcomes, including subtle thyroid dysfunction and autoimmune conditions. Diagnosing thyroid disorders in pregnancy is challenging due to overlapping symptoms with normal pregnancy changes and various contributing factors.

Methods: In this prospective observational study conducted in Mandi, Himachal Pradesh, we focused on pregnant women attending the first-trimester antenatal clinic. Inclusion criteria comprised pregnant women aged 18 or older, regardless of their gravidity and parity, who provided informed consent. Exclusions were made for comorbidities such as diabetes, hypertension, renal or liver disease, multifetal gestation, and previous bad obstetric history. A total of 300 hypothyroid pregnant women were selected through convenience sampling. We assessed serum thyroid-stimulating hormone (TSH) levels using chemiluminescent microplate immunoassay (CMIA) and administered adequate L thyroxine treatment to maintain TSH levels below 2.5 mIU/l.

Results: Maternal outcomes exhibited variation, with common delivery methods being cesarean sections (both emergency and elective) and normal vaginal deliveries. Some pregnancies faced complications, including gestational diabetes mellitus, preterm birth, and placenta previa. Neonatal outcomes ranged from healthy newborns to those with low Apgar scores, intrauterine demise, low birth weight, and stillbirth. Adequate treatment with L thyroxine was observed in 60.6% of cases, emphasizing the need for improved hypothyroidism management during pregnancy.

Conclusion: Our study underscores the diversity of maternal and neonatal outcomes associated with hypothyroidism during pregnancy in a hilly region of India. Early detection, comprehensive antenatal care, and optimal thyroid hormone management are vital to minimize complications and promote the well-being of both mothers and newborns. Further research and awareness campaigns are essential for enhancing thyroid disorder screening and management in pregnancy.

Downloads

Download data is not yet available.

References

Stagnaro Green A. Clinical review: maternal thyroid function and pregnancy outcomes: where do we go from here? J Clin Endocrinol Metab. 2013;98(8):2927-36.

De Groot L, Abalovich M, Alexander EK, Amino N, Linda Barbour RH, Cobin CJ, Luton, Susan J Mandel, Jorge Mestman, Joanne Rovet, Scott Sullivan. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-65.

Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-89. doi: 10.1089/thy.2016.0457, PMID 28056690.

Korevaar TIM, Derakhshan A, Taylor PN. The association of thyroid autoimmunity with thyroid function during pregnancy in a population-based cohort of women. J Clin Endocrinol Metab. 2016;101(4):3515-23.

Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91(7):2587-91. doi: 10.1210/jc.2005-1603, PMID 16621910.

Gowachirapant S, Winichagoon P, Wyss L, Tong B, Baumgartner J, Melse Boonstra A. Urinary iodine concentrations indicate iodine deficiency in pregnant Thai women but iodine sufficiency in their school-aged children. J Nutr. 2009;139(6):1169-72. doi: 10.3945/jn.108.100438, PMID 19403711.

Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-9. doi: 10.1056/NEJMoa040079, PMID 15254282.

Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017;356:i6865. doi: 10.1136/bmj.i6865, PMID 28122781.

Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549-55. doi: 10.1056/NEJM199908193410801, PMID 10451459.

Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95(4):1699-707. doi: 10.1210/jc.2009-2009, PMID 20130074.

Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat Endocrinol. 2005;4(1):31-41. doi: 10.2165/00024677-200504010-00004, PMID 15649099.

Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, De Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3 y follow-up study. Clinical Endocrinology. 2003;59(3):282-8. doi: 10.1046/j.1365-2265.2003.01822.x.

Cleary Goldman J, Malone FD, Lambert Messerlian G, Sullivan L, Canick J, Porter TF. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85-92. doi: 10.1097/AOG.0b013e3181788dd7, PMID 18591312.

Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7(3):127-30. doi: 10.1136/jms.7.3.127, PMID 11126160.

Korevaar TI, Schalekamp Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer Schrama SM. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab. 2013;98(11):4382-90. doi: 10.1210/jc.2013-2855, PMID 24037884.

Medici M, Korevaar TI, Schalekamp Timmermans S, Gaillard R, de Rijke YB, Visser WE. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab. 2014;99(12):E2591-8. doi: 10.1210/jc.2014-1505, PMID 25157540.